Kwizda Pharma

What Kwizda Pharma does

Kwizda Pharma GmbH is a privately held, family-owned Austrian pharmaceutical company headquartered in Vienna, founded in 1853, and operating as the pharmaceutical arm of the diversified Kwizda Group. It develops, manufactures, and markets a broad portfolio of over-the-counter (OTC) self-medication products, prescription (Rx) medications, and contract manufacturing services. Its OTC portfolio is anchored by the Bronchostop cough and cold brand — Austrian cough market leader since 2008 and ranked in the pan-European Top 10 — and extends across pain relief (Adolorin), vitamins and tonics (Leaton, D3 Kwizda, Biogelat), topical analgesics (Trauma-Salbe Mayrhofer), urological products (UroAkut, ellura), gastrointestinal (GastroBalance Reflu), and respiratory devices (Nasostop). Its Rx portfolio spans generic cardiovascular medications (ACE inhibitors, beta-blockers, calcium channel blockers), neurology, women's health, urology, gastroenterology, and gout. Contract manufacturing services include EU GMP-compliant non-sterile liquid dose manufacturing (batch sizes 100 to 9,000 liters), solid dose blistering and serialization, full analytical quality control (HPLC, HPTLC, NIR, FTIR, GC), and herbal medicinal product manufacturing, the latter leveraging integrated herbal procurement through the affiliated Kwizda Herbal Wholesale.

The company's business model is multi-stream. OTC and Rx products are sold through pharmacy distribution — exclusively via pharmacies in Austria and through local distribution partners across 30+ European markets plus select markets in Australia, Namibia, South Africa, and the UAE. Contract manufacturing is sold directly to enterprise pharmaceutical clients globally. GTM is channel-led: pharmacy distribution in the domestic market, distributor partnerships internationally, and direct enterprise sales for manufacturing services. An active business development team pursues in-licensing, acquisition, and exclusive distribution of late-stage Rx developments and registration-stage products, signaling an intent to scale the prescription portfolio. Within the Kwizda Group, Kwizda Pharma is the largest segment, with the group also encompassing plant protection and waterproofing systems industries outside healthcare.

Strategically, the company is in a steady, portfolio-broadening phase: 2024 and 2025 saw the launch of multiple new OTC SKUs in respiratory, pain, and gastrointestinal categories, alongside continued international rollout of the Bronchostop brand. The company is privately held with no public financial disclosure, no external institutional investment, and family ownership continuity. The product franchise is sustained by consistent regional industry recognition (UK OTC Awards 2020, Irish Pharmacy News Awards 2020/2023/2024, Meteoor Award Netherlands 2023, Careality Care Award Netherlands 2022).

Name

Kwizda Pharma

Legal name

Kwizda Pharma GmbH

Website

https://kwizda-pharma.at

Company type

Private

Founded year

1853

Operating status

Operating

Headcount range

101–250 employees

Short description

Kwizda Pharma is a family-owned Austrian pharmaceutical manufacturer founded in 1853, producing OTC self-medication products, prescription medications, and EU GMP contract manufacturing services, with the Bronchostop cough brand leading its OTC portfolio across 30+ European markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

akta.pro secondary industries

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)

Keywords

• Pharmaceutical manufacturing
• OTC medications
• Contract manufacturing
• Herbal medicinal products
• Prescription drugs

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. OTC Products: Over-the-counter pharmaceutical products including cough & cold remedies, pain relief, vitamins, and supplements sold through pharmacies.
2. Prescription Products: Prescription-only medications in therapeutic areas including hypertension, cardiovascular, gynecology, urology, neurology, gastroenterology, and gout.
3. Contract Manufacturing: EU GMP-compliant contract manufacturing of liquid dose forms, solid dosage forms, herbal medicinal products for pharmaceutical companies.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Kwizda Pharma GmbH develops, manufactures, and markets a portfolio of over-the-counter (cough, cold, pain, vitamins, urological, gastrointestinal) and prescription pharmaceuticals (cardiovascular, neurology, women's health, urology, gastroenterology, gout), distributed exclusively through pharmacies in Austria and via international partners across 30+ European markets. The company also provides EU GMP-compliant contract manufacturing of non-sterile liquid and solid dosage forms for pharmaceutical partners, leveraging in-house herbal raw material processing, liquid dose capability up to 9,000-liter batches, and full analytical quality control.

Product overview

Kwizda Pharma is an Austrian pharmaceutical company offering a comprehensive portfolio of OTC products, prescription medications, and contract manufacturing services. The OTC portfolio includes the BRONCHOSTOP line (cough syrups, lozenges, drops, and sprays for cold and cough), ADOLORIN pain relief products (ibuprofen-based), TRAUMA-SALBE topical analgesics (warming and cooling formulations), vitamin and mineral supplements (D3 Kwizda, CALCIUM VITAMIN D3, BIOGELAT line, LEATON tonics), urological products (UroAkut, ellura), gastrointestinal products (GastroBalance Reflu), and respiratory products (Nasostop Sinusitis Spray). The prescription portfolio spans cardiovascular medications (ACE inhibitors, beta-blockers, calcium channel blockers), neurological treatments, women's health products, urology, gastroenterology, and gout medications. Contract manufacturing services include liquid dose manufacturing (non-sterile liquids, sprays, syrups, suspensions), solid dose manufacturing (blister packaging, serialization), quality control testing (HPLC, HPTLC, NIR, FTIR, GC), and herbal medicinal products. The company operates EU GMP-compliant facilities and exports to over 30 markets throughout Europe.

Differentiator

Problem solved

Functional benefit

Brands

• Bronchostop: Market-leading cough and cold product line including syrups, lozenges, and sprays for throat and mouth care. Award-winning product available across Europe.
• Leaton
• TRAUMA-SALBE Mayrhofer
• D3 Kwizda
• CALCIUM VITAMIN D3
• GastroBalance Reflu
• ADOLORIN
• Nasostop

Products and services

• BRONCHOSTOP Cough Syrup Traditional plant-based medicinal product for cough relief containing thyme and marshmallow extracts; relieves the urge to cough and helps expectoration of thick phlegm associated with colds. Sold through pharmacies.
• BRONCHOSTOP sine Cough Syrup Alcohol-free traditional plant-based cough syrup with thyme and marshmallow extracts for dry cough relief and expectoration; suitable for children aged 2 and older.
• BRONCHOSTOP Duo Cough Lozenges Traditional plant-based lozenges combining thyme and marshmallow for relief of throat-irritation cough, non-productive cough, and productive cough with phlegm; suitable for adults and children aged 4 and older.
• BRONCHOSTOP Cough Lozenges (Mono) Thyme herb extract lozenges as a traditional plant-based medicinal product for relief of common-cold-related coughs.
• BRONCHOSTOP Children Cough Syrup Pediatric cough syrup formulated for children using plant-based active ingredients for relief of cold-related cough symptoms.
• BRONCHOSTOP Bronchitis akut Drops Herbal drops for acute bronchitis symptoms, part of the BRONCHOSTOP respiratory product line.
• BRONCHOSTOP Guaifenesine 10% acute Cough Drops Cough drops containing guaifenesin for acute cough relief, helping to loosen and expel mucus.
• BRONCHOSTOP direct Throat & Mouth Spray Spray for direct application to the throat and mouth for cough and cold symptom relief, part of the BRONCHOSTOP line.
• BRONCHOSTOP Reizhusten Saft BRONCHOSTOP Reizhusten Saft with the ReizStill formula (Icelandic Moss, Marshmallow + Hyaluronic Acid) targeted at irritating/tickly coughs; part of the BRONCHOSTOP cough & cold line.
• ADOLORIN Ibuforte EXPRESS Fast-acting ibuprofen lysinate analgesic for rapid and long-lasting pain relief in headaches, menstrual pain, toothache, and cold/flu symptoms; sold via pharmacies.
• ADOLORIN Ibuforte DIREKT 400 mg Ibuprofen 400 mg product in convenient stick format for intake without water, positioned under the ADOLORIN pain relief brand.
• ADOLORINI DIREKT 200 mg Ibuprofen 200 mg STICK TO GO product for practical intake without water, providing on-the-go pain relief; ADOLORIN sub-brand.
• TRAUMA-SALBE Mayrhofer warming Topical warming ointment for chronic conditions containing methyl salicylate and cayenne pepper extract; heat stimulates blood flow, relaxes muscles, joints and tendons, and eases pain.
• TRAUMA-SALBE Mayrhofer cooling Topical cooling ointment for acute injuries containing methyl salicylate and menthol; eases pain and reduces inflammatory response, oedema formation and hematoma.
• D3 Kwizda Dietary supplement with 3,000 I.U. vitamin D3 per tablet; supports normal muscle, immune system, cell division and bone function; free from gelatin and fructose.
• CALCIUM VITAMIN D3 Dietary supplement combining 500 mg calcium and 1,000 I.E. vitamin D3; supports bone mineralization and complements osteoporosis therapy; gastrointestinal well-tolerated.
• LEATON complete Vitality tonic containing 10 essential vitamins, caffeine, vermouth and 5 additional vital substances; provides energy boost during physical or mental exertion.
• LEATON classic Classic LEATON vitality and energy tonic with vitamins and herbal ingredients.
• LEATON sine Alcohol-free version of the LEATON vitality tonic.
• LEATON Kinder Children's version of the LEATON vitality tonic line.
• UroAkut Plant-based combination of D-Mannose and Cranberry with high content of Vitamins C, D3 and B3 for urinary tract health.
• ellura Product for prevention of recurrent uncomplicated infections of the lower urinary tract.
• GastroBalance Reflu 4-fold combination product against heartburn and reflux: builds a mechanical barrier, protects mucosa, helps regenerate mucosa and neutralizes stomach acid; free from lactose, gluten, and added sugar; suitable for vegetarians and vegans.
• Nasostop Sinusitis Spray Medical device with 100% natural active ingredient from cyclamen; frees nose and sinuses, promotes natural drainage of congested secretion, and reduces swelling of mucous membranes with no habituation effect.
• BIOGELAT Nutritional Supplement Line Range of BIOGELAT nutritional supplements including Biotin 5 mg (skin, hair, nails), Magnesium 375 mg, Vitamin E 400 mg, NaturCarotin combined, Cranberry UroForte (bladder health, vitamins C and E), Omega-3-Duo, and Lutein (eye health, macular density).
• MAGNESIUM VERLA supplements Range of magnesium supplements marketed under the MAGNESIUM VERLA brand, including PurKaps, direkt, 400 complex, 300 UNO granules, Sport Plus, and film-coated tablets.
• ZINK VERLA supplements Range of zinc supplements under the ZINK VERLA brand, including Zinkletten 5 mg, Zink Verla C, and Zink Verla 10 mg.
• EMGECARD 2.5 mmol Magnesium supplement in film-coated tablet form.
• SEDOGELAT Forte Traditional plant-based sedative containing valerian and melissa for sleep support.
• WORTIE cool Wart Remedy Cryotherapy wart treatment product for removal of common warts.
• VERALGIN Pflegespray Care spray for skin care use.
• KWIZDA First Aid Spray Spray for wound care and first-aid use.
• XENOFIT Heisse Hexe Vitamin supplement product line positioned for vitality support.
• ACETAN Prescription medication for the treatment of hypertension.
• AMLODIPIN Interpharm Prescription calcium channel blocker for the treatment of hypertension.
• BISOCOR Prescription beta-blocker for the treatment of angina pectoris and hypertension.
• MEPRIL Prescription ACE inhibitor (enalapril maleate) for the treatment of hypertension and heart failure.
• LISINOPRIL Interpharm Prescription ACE inhibitor for the treatment of hypertension and heart failure.
• CO-ACETAN / CO-ACETAN MITE Prescription combination medications (standard and lower-dose) for the treatment of hypertension.
• CO-MEPRIL Prescription combination of an ACE inhibitor and a diuretic for the treatment of hypertension.
• LISINOPRIL/HCT Interpharm Prescription combination of ACE inhibitor lisinopril with hydrochlorothiazide for hypertension.
• ERGOTOP Prescription neurological medication (nicergoline) for metabolism activation, increased blood flow, and improved blood circulation.
• MADONELLA / YRIS / FLUCOSEPT / LIBEREL Prescription medication portfolio for women's healthcare, spanning hormonal contraception, gynecological and urogenital conditions.
• FAMOTIDIN Interpharm Prescription H2 receptor antagonist for gastrointestinal conditions including acid-related disorders.
• ULCUSAN Prescription medication for gastroenterology.
• COLCTAB Prescription medication for the treatment of gout.
• FINASTERID Interpharm Prescription 5-alpha-reductase inhibitor indicated for urological conditions (benign prostatic hyperplasia).
• TAMSULOSIN Interpharm Prescription alpha-blocker indicated for benign prostatic hyperplasia.
• Lutrate 3-Months Depot Long-acting three-monthly injectable indicated for urological conditions (prostate cancer therapy).
• Liquid Dose Contract Manufacturing EU GMP-compliant contract manufacturing of non-sterile liquid dose forms (sprays, syrups, suspensions) for pharmaceutical partners. Batch sizes from 100 to 9,000 liters and pack sizes from 15 ml to 500 ml.
• Solid Dose Contract Manufacturing EU GMP-compliant contract manufacturing of solid oral dosage forms including blistering, packaging and serialization services for pharmaceutical partners.
• Quality Control Services Comprehensive analytical quality control for contract manufacturing partners using wet chemistry, physical methods, HPLC, HPTLC, NIR, FTIR, and GC; stability testing in accordance with ICH guidelines.
• Herbal Medicinal Products Contract Manufacturing EU GMP-compliant contract manufacturing of herbal medicinal products, leveraging long-term extract manufacturer relationships, extensive extract development knowledge, and regulatory expertise in national and EU registration procedures.

Quantifiable outcome

• Market leader in Austria for cough products since 2008
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Kwizda Herbal WholesalecoreStrategic or Co-development PartnerAffiliate company within Kwizda Group responsible for procurement of herbal drugs. Works with qualified GACP certified suppliers, treats herbal drugs with steam and/or CO2 according to GMP requirements, and provides comprehensive analytical determination of herbal drugs.
• Kwizda Pharmadistribution GmbHcoreStrategic or Co-development PartnerAffiliate company within Kwizda Group providing logistics services including storage areas at 15-25°C, 2-8°C and <-20°C with comprehensive temperature and humidity control, inbound deliveries and distribution.
• International Distribution PartnerscoreChannel Partner/ Reseller/ DistributorPartnerships with local distributors in over 30 European markets for distribution of Kwizda Pharma products including Bronchostop brand. Markets include Austria, Germany, UK, Ireland, Netherlands, Belgium, Spain, Italy, Poland, Hungary, Czech Republic, Slovakia, Slovenia, Croatia, Bulgaria, Romania, Serbia, and others.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Perrigo Company: US-headquartered but with significant European OTC presence, Perrigo is a major player in store-brand and branded consumer self-care products including cough/cold categories. Comparable in OTC focus and European pharmacy distribution model, though much larger scale.
• Haleon plc: Global consumer healthcare company spun off from GSK, with leading OTC brands across respiratory, pain, and vitamins globally. Direct competitor in cough/cold category with much larger marketing scale and international infrastructure.
• Bayer Consumer Health: Major OTC consumer health division of Bayer AG, including cough/cold products competing with Bronchostop in European markets. Significant scale advantage but overlapping therapeutic areas (respiratory, pain, vitamins).
• Mylan/Viatris: Global pharmaceutical company formed by Mylan-Upjohn combination, with strong European generics footprint and OTC presence. Comparable in generic Rx portfolio breadth across cardiovascular, urology, and women's health therapeutic areas.
• Teva Pharmaceutical Industries: Global generics leader with significant European OTC portfolio. Directly competes in generic Rx categories where Kwizda operates (ACE inhibitors, beta-blockers, calcium channel blockers). Massive scale advantage, but similar European tender-driven business model in generics.

Direct peers

• Almirall S.A. Spanish specialty pharmaceutical company focused on dermatology and specialty Rx with OTC presence. Comparable mid-cap European pharma profile with family/independent ownership history and similar international expansion trajectory through partnerships.
• Dermapharm Holding SE: German specialty pharmaceutical company focused on selected OTC, generics, and herbal medicines with strong European footprint. Highly comparable in product mix (herbal medicinal products, OTC consumer health) and European pharmacy distribution model.
• Stada Arzneimittel AG: German-based generics and specialty pharma company with strong OTC consumer health presence across Europe. Closely comparable business model combining generic Rx, OTC brands, and contract manufacturing. Similar European multi-market distribution approach and family/private equity ownership history.
• Zentiva Group: European generics and OTC pharmaceutical company headquartered in Prague, serving 50+ markets. Comparable in generic Rx portfolio breadth (cardiovascular, urology, etc.) and OTC consumer health focus, with similar European pharmacy-led distribution approach.

Regional players

• Ratiopharm (Teva Germany): German generics brand owned by Teva, dominant in German pharmacy generics market. Directly comparable OTC/generic Rx portfolio and German-speaking pharmacy distribution approach as a regional benchmark.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/kwizda-pharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kwizda Pharma